InNetics

InNetics was a pioneering systems biology company that specialized in the development of predictive computer models for cellular metabolism and signal transduction. The company's core technology, the InSilico Cell platform, utilized genome-scale reconstructions to simulate cellular behavior, providing a framework for drug target identification and metabolic engineering. Founded by leading researchers from the University of California, San Diego, InNetics provided high-value bioinformatics tools and services to the pharmaceutical and biotechnology industries. In 2001, the company was acquired by Physiome Sciences to integrate its metabolic modeling expertise into a comprehensive physiological simulation suite. The founders subsequently played significant roles in the evolution of the metabolic modeling and synthetic biology sectors.